Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinically mild encephalitis with a reversible splenial lesion (MERS) after mumps vaccination

Published:2015-02 Issue:1-2 Volume:349 Page:226-228
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Takanashi Jun-ichi,Shiihara Takashi,Hasegawa Takeshi,Takayanagi Masaru,Hara Munetsugu,Okumura Akihisa,Mizuguchi Masashi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference15 articles.

1. Mumps;Hviid;Lancet,2008

2. A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan;Nagai;Vaccine,2007

3. Mumps vaccine: present and future situations. In Japanese;Ihara;Rinsho To Uirusu,2010

4. Two newly proposed encephalitis/encephalopathy syndromes;Takanashi;Brain Dev,2009

5. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion;Tada;Neurology,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytotoxic Lesion of Corpus Callosum after COVID-19 Vaccination: Case Report;Acta Neurologica Taiwanica;2024-04

2. Cytotoxic Lesions of the Corpus Callosum (CLOCC) Suggesting Exacerbation by Heterogeneous COVID-19 Booster Vaccination;Cureus;2023-06-28

3. Reversible splenial lesion after surgery for distant arteriovenous malformation: a case report;Acta Neurochirurgica;2023-04-13

4. Refractory status epilepticus with fever due to mumps vaccine-induced encephalitis caused secondary encephalopathy mimicking acute encephalopathy with biphasic seizures and late reduced diffusion;Brain and Development;2022-11

5. CLOCC Patient after COVID-19 (BNT162b) Vaccine Improved by Steroid Treatment;Journal of the Korean Neurological Association;2022-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3